Manufacturer: Cipla, India
Pharmaceutical name: Beclomethasone
Pack: 1 inhaler (200 mcg/ 200 doses)
```html
The Beclate Inhaler is utilized to alleviate symptoms such as runny nose, nasal swelling, and itching caused by allergies (allergic rhinitis), hay fever, and ulcerative colitis. Beclometasone helps decrease inflammation, swelling, and irritation in the nasal passages, providing relief from itching, sneezing, and nasal congestion or discharge. Additionally, the Beclate Inhaler is effective in managing asthma and ulcerative colitis.
The Beclate inhaler contains Beclomethasone, the active component, which is a synthetic glucocorticoid. This substance is naturally produced by the adrenal glands and serves as an anti-inflammatory agent. Its design for targeted delivery to the lungs when inhaled makes it an excellent treatment option for those with asthma.
To use the Beclate inhaler, patients puff the medication through the mouth, directing it into the lungs, which allows it to effectively reach the affected area. The precise targeting of Beclomethasone reduces the likelihood of side effects typically associated with oral medications. It is generally well tolerated, helping to control asthma without hindering growth in children and facilitating easy airflow in the respiratory tract.
The primary active ingredient is Beclomethasone, which has a strong affinity for cytoplasmic receptors and inhibits the excessive production of inflammatory chemicals in the lungs. Beclomethasone focuses specifically on minimizing the factors that contribute to inflammation, thereby suppressing their accumulation and potentially preventing asthma-related issues.
Some potential side effects of the Beclate Inhaler include: coughing or sneezing, mild sore throat, delayed wound healing, thirst, dry mouth, slight headaches, facial swelling, throat or tongue swelling, skin rashes, or itching.
```